89Zr-S095012
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 89Zr-S095012, covering 2026-02-17 to 2026-02-17. Get the full timeline:
Most recent: Clinical Trial Update: Immuno-positron Emission Tomography Study of 89Zr-S095012 in Patients With Advanced Solid Tumours [Phase 1]